Journal of Clinical Endocrinology & Metabolism, Vol 81, 147-149, Copyright © 1996 by Endocrine Society

ARTICLES

Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene

DJ Gross, N Avishai, V Meiner, D Filon, B Zbar and D Abeliovich
Department of Endocrinology & Metabolism, Hadassah University Hospital, Jerusalem, Israel.

We report a three generation, 25 member kindred with familial pheochromocytoma. Seven subjects of generations I and II had pheochromocytoma, in five of the seven, the tumors were bilateral, and in two of the seven, the tumors were both adrenal and extraadrenal. One patient also had a carotid body chemodectoma, and one patient had a malignant adrenal tumor and abdominal paraganglioma. In the patient with the chemodectoma, a cerebellar hemangioblastoma became manifest 25 yr after his initial diagnosis with pheochromocytoma, leading only then to a clinical diagnosis of von Hippel-Lindau disease (VHL). A mutational analysis of the VHL gene revealed a novel nucleotide 709 G-- >T transversion present in all affected subjects and in four presymptomatic children. In familial pheochromocytoma the diagnosis of VHL should be considered, even when the formal criteria for diagnosis of the syndrome are lacking.

This article has been cited by other articles:

				D. J. Gross, I. Reibstein, L. Weiss, S. Slavin, H. Dafni, M. Neeman, M. Pines, and A. Nagler Treatment with Halofuginone Results in Marked Growth Inhibition of a von Hippel-Lindau Pheochromocytoma in Vivo Clin. Cancer Res., September 1, 2003; 9(10): 3788 - 3793. [Abstract] [Full Text] [PDF]

				G. Weirich, B. Klein, T. Wohl, D. Engelhardt, and H. Brauch VHL2C Phenotype in a German von Hippel-Lindau Family with Concurrent VHL Germline Mutations P81S and L188V J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5241 - 5246. [Abstract] [Full Text] [PDF]

				C. A. KOCH, A. O. VORTMEYER, Z. ZHUANG, F. M. BROUWERS, and K. PACAK New Insights into the Genetics of Familial Chromaffin Cell Tumors Ann. N.Y. Acad. Sci., September 1, 2002; 970(1): 11 - 28. [Abstract] [Full Text] [PDF]

				B E Baysal Hereditary paraganglioma targets diverse paraganglia J. Med. Genet., September 1, 2002; 39(9): 617 - 622. [Abstract] [Full Text] [PDF]

				G. Eisenhofer, M. M. Walther, T.-T. Huynh, S.-T. Li, S. R. Bornstein, A. Vortmeyer, M. Mannelli, D. S. Goldstein, W. M. Linehan, J. W. M. Lenders, et al. Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1999 - 2008. [Abstract] [Full Text]

				D. J. Gross, I. Reibstein, L. Weiss, S. Slavin, I. Stein, M. Neeman, R. Abramovitch, and L. E. Benjamin The Antiangiogenic Agent Linomide Inhibits the Growth Rate of von Hippel-Lindau Paraganglioma Xenografts to Mice Clin. Cancer Res., November 1, 1999; 5(11): 3669 - 3675. [Abstract] [Full Text] [PDF]